Logo image
RACK1 and CIS Mediate the Degradation of BimEL in Cancer Cells
Journal article   Open access   Peer reviewed

RACK1 and CIS Mediate the Degradation of BimEL in Cancer Cells

Weizhou Zhang, George Zhi Cheng, Jianli Gong, Ulrich Hermanto, Cong Susan Zong, Joseph Chan, Jin Quan Cheng and Lu-Hai Wang
The Journal of biological chemistry, Vol.283(24), pp.16416-16426
06/13/2008
DOI: 10.1074/jbc.M802360200
PMCID: PMC2423247
PMID: 18420585
url
https://doi.org/10.1074/jbc.M802360200View
Published (Version of record) Open Access

Abstract

RACK1 is a 7-WD motif-containing protein with numerous downstream effectors regulating various cellular functions. Using a yeast two-hybrid screen, we identified dynein light chain 1 as a novel interacting partner of RACK1. Additionally, we demonstrated that RACK1 formed a complex with DLC1 and Bim, specifically BimEL, in the presence of apoptotic agents. Upon paclitaxel treatment, RACK1, DLC1, and CIS mediated the degradation of BimEL through the ElonginB/C-Cullin2-CIS ubiquitin-protein isopeptide ligase complex. We further showed that RACK1 conferred paclitaxel resistance to breast cancer cells in vitro and in vivo. Finally, we observed an inverse correlation between CIS and BimEL levels in both ovarian and breast cancer cell lines and specimens. Our study suggests a role of RACK1 in protecting cancer cells from apoptosis by regulating the degradation of BimEL, which together with CIS could play an important role of drug resistance in chemotherapy.

Details

Metrics

Logo image